Skip to main navigation

Top Navigation

Publications
Newsroom
Investors
Blog
Careers
Contact Us

mRNA Technology
Modalities
Pipeline
- Clinical Trials
- Therapeutic Areas
Citizenship
- Corporate Responsibility
About Us

Investors

IR Navigation

Overview
Stock Information
Corporate Governance
SEC Filings
Events & Presentations
Press Releases
Shareholder Resources
Statements & Perspectives

Investor Relations

Day High

Day Low

Volume

4:11 AM EST
March 4, 2021

Copyright West LLC.
Minimum 15 minutes Delayed.

Press Releases

February 25, 2021

Moderna Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Updates

February 24, 2021

Moderna Announces Additional Capital Investments to Increase Global Manufacturing Capacity for COVID-19 Vaccine

February 24, 2021

Moderna Announces it has Shipped Variant-Specific Vaccine Candidate, mRNA-1273.351, to NIH for Clinical Study

View All Press Releases

Events

Mar 11, 2021 at 10:20 AM EST

Barclays Global Healthcare Conference

Mar 16, 2021 at 1:50 PM EDT

Oppenheimer 31st Annual Healthcare Conference

View All Events

Presentations

Corporate Presentation

Annual R&D Day Presentation

Annual Science Day Presentation

Pipeline Program Detail

IR Contact

IR@modernatx.com

Email Alerts

Click Here to have company news delivered to your inbox

mRNA Technology
Modalities
Pipeline
Citizenship
About Us

Publications
Newsroom
Investors
Blog
Careers
Contact Us

Facebook
Twitter
Youtube
LinkedIn

Footer Menu - Bottom

© 2021 Moderna, Inc.
Privacy Policy
Join our Mailing List
Terms of Use

×

You are now leaving investors.modernatx.com, a website provided by Moderna. This link will take you to a website to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every website you visit. The content displayed on external websites is not controlled by Moderna, and Moderna assumes no responsibility for the information or statements on such external websites.